The present invention relates to chemical compounds of formula (I), with the substituents as described in the specification, useful in the positive modulation of the alpha 7 nicotinic acetylcholine receptor (α7 nAChR). The invention also relates to the use of these compounds in the treatment or prevention of a broad range of diseases in which the positive modulation of α7 nAChR is advantageous, including neurodegenerative and neuropsychiatric diseases and also neuropathic pain and inflammatory diseases.
本发明涉及
化学式(I)的化合物,其取代基如规范中所述,在正向调节α7
尼古丁乙酰胆碱受体(α7 nAChR)中有用。该发明还涉及这些化合物在治疗或预防广泛范围的疾病中的应用,其中正向调节α7 nAChR是有利的,包括神经退行性和神经精神疾病,以及神经病性疼痛和炎症性疾病。